Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Levander Life Science Consulting AB
AB
Active
Org 5594162322
Spetsbergsvägen 10
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,3M
-3% vs 2024
EBITDA margin
20.6%
-36% vs 2024
Equity ratio
45.9%
Financial strength
Net profit 2025
SEK 368K
-37% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 2,3M
-3%
EBITDA
SEK 466K
-36%
Net profit
SEK 368K
-37%
Total assets
SEK 857K
-2%
Equity
SEK 394K
-35%
Employees
2
—
Company information
Legal name
Levander Life Science Consulting AB
Org number
5594162322
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 januari 2023
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget bedriver konsultverksamhet inom Life science samt därmed förenlig verksamhet.
Contact
Address
Spetsbergsvägen 10
Email
sepideh@levanderconsulting.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Haninge
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
2 333
2 269
Staff expenses
−1 170
−1 312
EBITDA
731
466
Depreciation & amort.
—
—
EBIT
731
466
Net financials
0
−0
Profit before tax
731
466
Tax
−151
−98
Net profit
580
368
Balance sheet
SEK thousands
Item
2024
2025
Total assets
872
857
Equity
605
394
Long-term debt
—
—
Short-term debt
268
464
Total debt
268
464
Financial ratios
5-year trend
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
2024
2025
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
2024
2025
Return on equity
93.5%
This company
18.4%
Market median
+408% vs market
2024
2025
Net profit margin
16.2%
This company
8.1%
Market median
+100% vs market
2024
2025
Asset turnover
2.65×
This company
1.12×
Market median
+137% vs market
2024
2025
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-01-02 – 2024-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JM
Johnny Mattias Levander
Deputy Board Member
2023
SL
Sepideh Levander
Board of Directors
2023
Former (4)
MH
M H Charlotte Wiberg Larsson
Chairman
2023 – 2023
BT
Bo Torsten Nilsson
Board of Directors
2023 – 2023
PJ
Peter Jonas Michael Carlborg
Deputy Board Member
2023 – 2023
BT
Bo Torsten Patrik Nilsson
Deputy Board Member
2023 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Levander Life Science Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
M H Charlotte Wiberg Larsson
Chairman
0 companies
Bo Torsten Nilsson
Board of Directors
0 companies
Johnny Mattias Levander
Deputy Board Member
0 companies
Sepideh Levander
Board of Directors
0 companies
Peter Jonas Michael Carlborg
Deputy Board Member
0 companies
Bo Torsten Patrik Nilsson
Deputy Board Member
0 companies